Creo Medical (AIM: CREO)

Last close As at 05/08/2026

GBP0.13

−0.38 (−2.83%)

Market capitalisation

GBP58m

UK-based Creo Medical focuses on the development and commercialisation of minimally invasive electrosurgical devices. Its six products in the flagship CROMA platform have all been CE marked, with five cleared by the FDA. Acquired in 2020, Albyn Medical provides Creo with profitable products and a direct salesforce in Europe.

Latest Insights

View More

Healthcare | Comment

Creo Medical’s (LSE: CREO) H126 results build momentum

Healthcare | Quickview

Creo Medical — Leaner structure, sharper focus

Healthcare | Flash

Creo Medical — FY25 results validate growth strategy

creo05

Market Data

Share Price GBP0.13
Market Cap GBP58m
52-Week High GBP0.18
52-Week Low GBP0.10
% Change 1M (12.7)
% Change 6M (26.4)
% Change 12M (1.9)
Ave. Daily Volume 1yr 718,192

Sector

Healthcare

Equity Analyst

Jyoti Prakash

Jyoti Prakash, CFA

Director, healthcare

Key Management

  • Craig Gulliford

    CEO

  • David Woods

    Chief commercial officer

  • Richard Rees

    CFO

Share Price Chart

Thematics

Cookie Policy Overview
Edison Group

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping us understand which section of the website you find more interesting and useful. See our Cookie Policy for more information.

Strictly necessary and functional

These cookies are used to deliver our website and content. Strictly necessary cookies relate to our hosting environment, and functional cookies are used to facilitate social logins, social sharing and rich-media content embeds.

Advertising

Advertising Cookies collect information about your browsing habits such as the pages you visit and links you follow. These audience insights are used to make our website more relevant.

Performance

Performance Cookies collect anonymous information designed to help us improve the site and respond to the needs of our audiences. We use this information to make our site faster, more relevant and improve the navigation for all users.